title: Molecular MRI of VEGFR-2 reveals intra-tumor and inter-tumor heterogeneity.
abstract: Non-invasive and quantitative imaging of vascular endothelial growth factor receptor-2 (VEGFR-2) expression levels is highly important in cancer diagnosis, prognosis, and patient management. Although various literature reports have investigated the tumor expression levels of VEGFR-2 using imaging techniques such as positron emission tomography, single-photon emission computed tomography, targeted ultrasound, etc., accurate evaluation of the dynamic microdistribution of VEGFR-2 in vivo with good spatial and temporal resolution remains a major challenge. In this issue of the American Journal of Nuclear Medicine and Molecular Imaging, He at al. reported the use of a VEGFR-2 targeted probe for magnetic resonance imaging (MRI) of VEGFR-2 in two glioma models in rats (i.e. C6 and RG2). The heterogeneity of VEGFR-2 expression was non-invasively imaged with MRI and validated with various in vitro, in vivo, and ex vivo experiments. Not only was heterogeneous expression of VEGFR-2 found in different glioma tumors, it was also observed in different regions within the same tumor (e.g. tumor periphery, peri-necrotic area, and tumor interior). This report highlights the complex nature of gliomas, which may offer invaluable insights into tumor heterogeneity and potential clinical management of glioma patients. These patients have dismal clinical outcomes and are in urgent need of better tools to improve brain tumor treatment.
authors.affiliation: Department of Radiology, University of Wisconsin - Madison WI, USA.
authors.forename: Feng
authors.initials: F
authors.lastname: Chen
authors.forename: Yin
authors.initials: Y
authors.lastname: Zhang
authors.forename: Weibo
authors.initials: W
authors.lastname: Cai
keywords: Molecular MRI (mMRI); VEGFR-2; glioma; molecular imaging; tumor angiogenesis
references.citation: Am J Nucl Med Mol Imaging. 2012 Jul 10;2(3):273-306
references.pmid: 22943038
references.citation: Br J Radiol. 2011 Dec;84 Spec No 2:S159-67
references.pmid: 22433826
references.citation: Cell. 2011 Mar 4;144(5):646-74
references.pmid: 21376230
references.citation: Am J Nucl Med Mol Imaging. 2013 Apr 09;3(3):194-216
references.pmid: 23638333
references.citation: Mol Imaging Biol. 2009 Jan-Feb;11(1):15-22
references.pmid: 18784964
references.citation: Physiol Rev. 2012 Apr;92(2):897-965
references.pmid: 22535898
references.citation: Am J Nucl Med Mol Imaging. 2013 Jul 10;3(4):300-11
references.pmid: 23901356
references.citation: Nat Rev Cancer. 2002 Oct;2(10):795-803
references.pmid: 12360282
references.citation: J Cell Mol Med. 2011 Apr;15(4):837-49
references.pmid: 20497492
references.citation: Chem Soc Rev. 2012 Feb 7;41(3):1323-49
references.pmid: 22008740
references.citation: Nat Rev Cancer. 2003 Jun;3(6):401-10
references.pmid: 12778130
references.citation: Front Biosci. 2007 May 01;12:4267-79
references.pmid: 17485373
references.citation: J Nucl Med. 2008 Jun;49 Suppl 2:113S-28S
references.pmid: 18523069
references.citation: Curr Pharm Des. 2008;14(28):2943-73
references.pmid: 18991712
references.citation: Radiology. 2011 Mar;258(3):804-11
references.pmid: 21339349
references.citation: Am J Nucl Med Mol Imaging. 2011;1(1):65-75
references.pmid: 23133797
references.citation: Nat Med. 1995 Jan;1(1):27-31
references.pmid: 7584949
references.citation: Am J Nucl Med Mol Imaging. 2012;2(1):55-76
references.pmid: 23133802
references.citation: Brain Pathol. 2005 Oct;15(4):342-63
references.pmid: 16389946
references.citation: Endocr Rev. 2004 Aug;25(4):581-611
references.pmid: 15294883
references.citation: Cancer Res. 1995 Mar 1;55(5):1189-93
references.pmid: 7532545
references.citation: Am J Nucl Med Mol Imaging. 2013;3(1):1-15
references.pmid: 23342297
references.citation: Eur J Nucl Med Mol Imaging. 2007 Dec;34(12):2001-10
references.pmid: 17694307
references.citation: Nat Rev Neurosci. 2007 Aug;8(8):610-22
references.pmid: 17643088
references.citation: Nat Med. 2007 Apr;13(4):504-9
references.pmid: 17351626
references.citation: Int J Clin Exp Med. 2011;4(1):32-42
references.pmid: 21394284